Media

ABOUT THE 5TH ANNUAL IMMUNO-ONCOLOGY FORUM ​ Taking place on the first day of ASCO, the 5th Annual Immuno-Oncology BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient

May 24, 2019 20:05 UTC ROCKVILLE, Md.--(BUSINESS WIRE)-- Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will present at the 5th Annual Immuno-oncology

April 04, 2019 04:05 PM Eastern Daylight Time ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc. announced today that it will participate at the World Vaccine Congress Washington being held in Washington, D.C.

Poster Title: DNA vaccine co-expressing Her2/ErbB2 antigen, fused with LAMP, elicits strong antitumor effects in vivo by increasing tumor infiltration with CD8+ T cells Session Category: Immunology Session Title: Late-Breaking

Immunomic Therapeutics, Inc. today presented late-breaking preclinical data which shows that its investigational nucleic acid platform, UNITE, may enhance antitumor immunity when used in connection with its investigational DNA vaccine,

ITI will be sponsoring the World Vaccine and Immunotherapy Congress for the second year in a row.  After an incredibly successful two years in San Diego, the World Vaccine and

The Society for Immunotherapy of Cancer (SITC) Annual Meeting & Pre-Conference Programs brings together stakeholders across the cancer immunotherapy field to advance the science, discover breakthroughs and educate the world

BIO 2019 - June 3-6 - Philadelphia, PA Join BIO in Philadelphia, PA, June 3-6, 2019 as more than 16,000 attendees from around the globe gather for unparalleled partnering, education,

2019 ASCO Annual Meeting Caring for Every Patient, Learning from Every Patient | #ASCO19 https://meetings.asco.org/am/register-submit-abstracts

ITI will be sponsoring The Race for Hope-DC for the 2nd year in a row.  The Race for Hope is a 5K course in the nation's capital, is a fun

R & D + Strategic Partnering For The Global Vaccine Industry For the third year in a row, ITI is a sponsor and will be speaking on a panel at the World

This invitation-only event is free for executive level biotech leaders and is presented by BioHealth Innovation, VirginiaBio, Children’s National Health System,  Maryland Tech Council, Hemoshear Therapeutics, Maryland Department of Commerce,